Forum Logikmemorial
Comment fonctionne notre forum => Accueil => Discussion démarrée par: MethrenRaf le Mai 07, 2024, 08:51:30 pm
-
Mahd NIH Awards Cellular Dynamics International SBIR Grant to Develop Human Cardiomyocytes for Drug Screening
Quest Diagnostics and nike sb dunk (https://www.nike-dunk.es) Hologic, Inc. announced that they have entered into a st yeezy 350 (https://www.yeezyy.at) rategic alliance to more broadly offer testing based on Hologic's APTIMA family of products, as well as to co-develop and promote advanced diagnostic solutions to improve women's health."This alliance will enhance the ability of Quest Diagnostics to deliver state-of-the-art testing methods and specialized expertise in women's health diagnostic information services," said Steve Rusckowski, President and Chief Executive Officer, Quest Diagnostics. "It builds on our long-standing successful relationship with Hologic to lead the way in delivering solutions that address the clinical challenges facing obstetricians and gynecologists in treating women. This collaboration also promises to increase the rang dunk high nike (https://www.nike-dunks.de) e of capabilities for advancing the health of women for both companies.""This collaboration represents a potentially important new chapter in women's health diagnostics," said Rob Cascella, Hologic's President and C KARACHI:Mari Petroleum Limited (MARI) posted a profit of Rs2.8 billion (earnings per share or EPS of Rs25.7) in the fourth quarter ending on June 30, up 31% year-on-year, according to a company notice sent to the Pakistan Stock Exchange (PSX).With this, the company earnings in fiscal year 2016-17 (FY17) summed up to Rs9.1 billion (EPS of Rs82.87), up by a stellar 51% year-on-year.Govt decides to divest 18.3% stake in Mari PetroleumSimilarly, dividend pay-out has increased to Rs5.91 per share compared to 5.10 per share in the same period of last year. KSE-100 Index remained stanley-cup (https://www.stanley-cup.us) flat and closed at 45,905, down 2 points or 0.01%. Mari Petroleum share price closed at R new balance rosa (https://www.nbbalance.it) s1,651.82, up 0.95% from its last day鈥檚 closing price.Net sales of the company grew to Rs8.3 billion in the fourth quarter of FY17. The increase in topline new balance pour homme (https://www.nbbalance.fr) on a year-on-year basis stems from unwinding of entitlement factor to 73.2% during second half of FY17 (in first half of FY17 it was 66.5%).The company鈥檚 exploration cost decl